本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Larimar Therapeutics, Inc.

2.01
+0.10005.24%
成交量:115.91万
成交额:231.59万
市值:1.29亿
市盈率:-1.53
高:2.06
开:1.88
低:1.87
收:1.91
数据加载中...
2024/03/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/12

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report